Quinidine hydrochloride monohydrate
Quinidine hydrochloride monohydrate is an anti-arrythmic agent which is also a potent blocker of K+ channel with an IC50 of 19.9 μM[1][2].
Product Specifications
CAS Number
6151-40-2
UNSPSC
12352005
Hazard Statement
H302, H316, H317, H335
Target
Parasite; Potassium Channel
Type
Natural Products
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Quinidine_hydrochloride_monohydrate.html
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 2.5 mg/mL (ultrasonic)
Smiles
C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2([H])[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34.[H]Cl.[H]O[H]
Molecular Formula
C20H27ClN2O3
Molecular Weight
378.89
Precautions
H302, H316, H317, H335
References & Citations
[1]Wrighton DC, et al. Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium. Br J Pharmacol. 2015 Sep;172 (17) :4355-63.|[2]Cheng KI, et al. Application of quinidine on rat sciatic nerve decreases the amplitude and increases the latency of evoked responses. J Anesth. 2014 Aug;28 (4) :559-68.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Launched
Isoform
Plasmodium
Citation 01
Cell Mol Life Sci. 2025 Nov 25;82 (1) :419.|Pharmaceutics. 2025 Mar 26;17 (4) :423.|AAPS J. 2021 Jun 28;23 (4) :91.|Adv Sci (Weinh) . 2025 Aug 19:e05666.|Anal Chem. 2025 Nov 18;97 (45) :25158-25167.|Andrology. 2024 Nov 05.|Chemosphere. 2021 Dec:284:131347.|Environ Int. 2019 Jun;127:694-703. |Environ Pollut. 2024 May 25:124214.|Eur J Drug Metab Pharmacokinet. 2022 Sep;47 (5) :639-652.|Food Chem Toxicol. 2022 Nov:169:113431.|Front Pharmacol. 2020 Jul 31;11:1038.|J Agric Food Chem. 2022 Mar 2;70 (8) :2520-2528.|J Anim Sci. 2022 Apr 1;100 (4) :skac069.|J Hazard Mater. 2021 Aug 15:416:125764.|J Med Chem. 2020 Oct 8;63 (19) :11085-11099.|J Med Chem. 2021 Mar 11;64 (5) :2725-2738.|Pharmacol Res Perspect. 2020 Apr;8 (2) :e00575.|Pharmacol Res Perspect. 2021 Oct;9 (5) :e00879.|RSC Adv. 2019 May 23;9 (28) :16136-16146.|Virol J. 2024 Aug 8;21 (1) :181.|Nat Commun. 2024 Jun 19;15 (1) :5230.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740225-100 1x 100 µL
Major Vault Protein (MVP) (1032), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740429-100 1x 100 µL
CD19 (CVID3/429), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details